Number of Treatment Admissions for Benzos Nearly Triples

xanaxIt is no secret that prescription drugs have become the biggest substance abuse problem in the country, but one set of pharmaceuticals often get overlooked – benzodiazepines. While it is true that painkillers overshadow these drugs in terms of total number of users and treatment admissions, government survey information shows that the benzo problem in America has nearly tripled in just the last decade.

Benzodiazepines, often called benzos, are prescription tranquilizers that include drugs such as Xanax, Klonopin, Valium, Librium, Ativan and others. In 2001 there were 6,400 treatment admissions in America where the primary substance listed was a benzo. This number steadily increased each year, hitting an all-time high of over 17,400 by 2011.

These drugs can be particularly dangerous when abused since they carry a high risk of seizure. They also can produce some delayed withdrawal symptoms that may include anxiety and paranoia, among other things.

In addition to the statistics mentioned above, we have seen a very noticeable increase in the number of people seeking intervention help for benzos. If you have a loved one dependent on prescription drugs or abusing another substance, call Family First Intervention today for more information.

Mike Loverde

With firsthand experience with addiction, Mike Loverde is now a Certified Intervention Professional (CIP), as accredited by the Association of Intervention Specialists and the Pennsylvania Certification Board. He founded Family First Intervention in 2008 and has since helped hundreds of families find intervention and addiction rehabilitation solutions.

Scroll below to see the latest blog articles from the desk of Mike Loverde. He shares his years of expertise on various addiction, mental health and intervention topics. If you have any questions about any of the material or want to inquire about our intervention services, don’t hesitate to contact us anytime.

More Posts - Website

Follow Me:
TwitterFacebookLinkedIn